Previous close | 21.82 |
Open | 22.09 |
Bid | 21.55 x 200 |
Ask | 21.83 x 200 |
Day's range | 21.30 - 22.16 |
52-week range | 4.55 - 27.72 |
Volume | |
Avg. volume | 258,181 |
Market cap | 1.241B |
Beta (5Y monthly) | 1.44 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.47 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 56.55 |
It's shaping up to be a tough period for Silence Therapeutics plc ( NASDAQ:SLN ), which a week ago released some...
Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript March 13, 2024 Silence Therapeutics plc misses on earnings expectations. Reported EPS is $-0.47 EPS, expectations were $-0.25. SLN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
Silence Therapeutics ( NASDAQ:SLN ) Full Year 2023 Results Key Financial Results Revenue: UK£25.4m (up 45% from FY...